SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bentway
To: DMaA who wrote (606146)8/26/2016 2:34:57 PM
From: DewDiligence_on_SI1 Recommendation  Read Replies (2) of 793659
 
You don't need a conspiracy. It's in plain sight. The reason a company with a product so old its patent is expired can maintain monopoly pricing is because of government regulations.
You're missing the point. The drug in EpiPen (epinephrine) is old, but the injection device is not. To get FDA approval for a generic version of EpiPen, the generic product must exactly replicate the EpiPen injection device.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News